Meeting Banner
Abstract #3303

Quantitative imaging biomarkers of demyelination and remyelination: reproducibility of MTsat vs. MTR.

Beth York1,2, Michael J. Thrippleton1,2, Rozanna Meijboom1,2,3, and Adam Waldman1,2,4

1Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom, 2Edinburgh Imaging, Edinburgh, United Kingdom, 3UK Dementia Research Institute, University of Edinburgh, Edinburgh, United Kingdom, 4Imperial College London, London, United Kingdom

MTsat provides magnetization transfer information less confounded by B1 and T1 inhomogeneities than MTR (largely derived from bound protons within axonal myelin in the brain). The present study measured the reproducibility of MTsat versus MTR, and compared tissue-type contrast for MTsat and MTR in healthy volunteers and patients with relapsing-remitting multiple sclerosis. Quantitative maps were created for histogram analysis, descriptive statistics and sensitivity comparisons. MTsat and MTR showed similar reproducibility but MTsat showed higher tissue contrast. Our data suggest MTsat is a superior biomarker for myelin integrity, with utility for the study of demyelination and remyelinating therapies in multiple sclerosis.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords